Case Overview: A lawsuit investigation has been launched following an Omnipod 5 insulin pump recall linked to serious health complications, including diabetic ketoacidosis (DKA) and diabetic coma.

Consumers Affected: People who used the Omnipod 5 insulin pump and experienced serious health complications

Court: To be determined

Omnipod 5 Insulin Pump Recall Linked to DKA, Diabetic Coma in New Lawsuit Investigation

A lawsuit investigation is underway targeting the Omnipod 5 insulin pump after a product recall was linked to reports of serious and potentially life-threatening health complications, including diabetic ketoacidosis (DKA) and diabetic coma. According to a recent investigation reported by Top Class Actions, affected users may have legal options against the device's manufacturer.

The Omnipod 5 is a tubeless, wearable insulin delivery system used by people with diabetes to manage blood sugar levels. Unlike traditional insulin pumps, the device operates wirelessly and is designed to automate insulin delivery through a smartphone app. Its widespread adoption among diabetic patients has made the recall and alleged safety failures a matter of significant concern.

Recalled Device Allegedly Failed to Deliver Insulin Safely

At the center of the investigation is an Omnipod 5 recall tied to reports that the device malfunctioned in ways that disrupted proper insulin delivery. When an insulin pump fails to deliver the correct dose of insulin, blood sugar levels can rise sharply and without warning — a dangerous condition for diabetic patients who rely on the device to regulate a bodily function their pancreas can no longer perform adequately on its own.

The investigation alleges that these malfunctions placed users at risk of DKA, a serious complication that occurs when the body produces high levels of blood acids called ketones. Left untreated, DKA can escalate rapidly and lead to diabetic coma or death.

Serious Complications Reported by Patients

Among the health consequences linked to the recalled Omnipod 5 are:

• Diabetic ketoacidosis (DKA) — a potentially fatal buildup of ketones in the bloodstream
• Diabetic coma — a life-threatening loss of consciousness caused by dangerously high or low blood sugar
• Other serious injuries allegedly stemming from inadequate insulin delivery

For diabetic patients — particularly those with Type 1 diabetes who depend entirely on external insulin delivery — a malfunctioning pump is not a minor inconvenience. It can become a medical emergency within hours.

Who May Be Affected

The investigation is focused on individuals who used the Omnipod 5 Automated Insulin Delivery System and experienced serious health complications that may be connected to a device malfunction or the recall. Patients who suffered DKA, required hospitalization, or experienced other significant adverse health events while using the device may be eligible to participate in litigation, according to the investigation.

Insulet Corporation, the Massachusetts-based company behind the Omnipod product line, markets the Omnipod 5 as a next-generation automated insulin delivery system. The device received FDA clearance in 2022 and has been widely adopted, particularly among younger patients and those seeking a more discreet alternative to traditional tubed pumps.

Device Recalls and Manufacturer Liability

When a medical device is recalled after reports of serious injury, manufacturers may face legal exposure under several theories, including defective design, manufacturing defects, and failure to warn patients and prescribing physicians about known risks. In cases involving implanted or wearable medical devices, courts have increasingly examined what manufacturers knew about potential failure modes — and when they knew it.

A device receiving FDA clearance does not necessarily insulate a manufacturer from liability under state law. Plaintiffs in medical device cases frequently argue that regulatory approval represents a floor, not a ceiling, for safety obligations.

Insulet Corporation has not been named as a defendant in a filed complaint at the time of publication, and no court has made findings against the company. The investigation is ongoing.

Related Cases

• Philips CPAP Recall Lawsuit: Respiratory Injuries Alleged
• Insulin Pricing Lawsuit Targets Major Manufacturers
• Medical Device MDL Consolidation: What Patients Need to Know

Lawsuit: Investigation ongoing; no complaint publicly filed at time of publication

Case Number: Pending

Court: To be determined

Plaintiffs' Attorney(s): To be determined

This article is for informational purposes only. Consult your doctor before making any changes to your medication or medical device use.

Have you or someone you know used the Omnipod 5 insulin pump and experienced a serious health complication? Share your experience in the comments below.